Stock listing
Sinovac Biotech, Ltd.
Selected listing: SVA · NASDAQ · USD · US
Sinovac Biotech, Ltd. (NASDAQ:SVA), Health Technology. Latest release Aug 17, 2026: SINOVAC Reports Unaudited First Half of 2026 Financial Results.
- Ticker
- NASDAQ:SVA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Sinovac Biotech, Ltd.
Sinovac Biotech, Ltd. is a public company traded under the ticker SVA in the American market. Sinovac focuses on the development and commercialization of vaccines and biopharmaceutical products.
Latest news from Sinovac Biotech, Ltd.
SINOVAC Reports Unaudited First Half of 2026 Financial Results
August 17, 2026
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
June 15, 2026
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
June 5, 2026
Sinovac Biotech : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F)
June 5, 2026
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
May 29, 2026
Research Sinovac Biotech, Ltd.
Sinovac Biotech, Ltd. company profile
View the public company page for Sinovac Biotech, Ltd. on 6ix.
Sinovac Biotech, Ltd. news
Read company news and market updates connected to Sinovac Biotech, Ltd..
Sinovac Biotech, Ltd. investor events
Find investor webinars, events, and replay context for Sinovac Biotech, Ltd..